Lv3
350 积分 2026-05-07 加入
Impact of Major Depressive Disorder on Comorbidities
4天前
已完结
Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections
12天前
已关闭
Targeting glutamate signalling in depression: progress and prospects
12天前
已完结
Searching for factors associated with the “Revolving Door phenomenon” in the psychiatric inpatient unit: A 5-year retrospective cohort study
16天前
已完结
[Paranoid schizophrenic patient with unstable spinal fracture]
16天前
已关闭
Attitudes Toward Medications and the Relationship to Outcomes in Patients with Schizophrenia
16天前
已关闭
Erratum to: Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: a cost effectiveness study
16天前
已完结
Evaluation of Potentially Prolactin-Related Adverse Events and Sexual Maturation in Adolescents with Schizophrenia Treated with Paliperidone Extended-Release (ER) for 2 Years: A Post Hoc Analysis of an Open-Label Multicenter Study
16天前
已完结
Targeting the dopamine D2receptor in schizophrenia
16天前
已完结
Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression: Assessment of Long-Term Safety in a Phase 3, Open-Label Study (SUSTAIN-2)
17天前
已完结
皖公网安备34019202002308
